Category: Include on Menu

  • Pagaya Shares Sink Despite Q4 Profit Beat as Revenue and Outlook Disappoint

    Pagaya Shares Sink Despite Q4 Profit Beat as Revenue and Outlook Disappoint

    Pagaya Technologies Ltd. (NASDAQ:PGY) shares plunged more than 20% in premarket trading on Monday after the company reported fourth-quarter results that beat earnings expectations but missed on revenue and came with weaker-than-expected guidance. Pagaya posted adjusted earnings of $0.80 per share for the fourth quarter, well ahead of the analyst consensus of $0.35. Revenue, however,…

  • PowerFleet Shares Slip Despite Record Q3 Revenue and Profit Gains

    PowerFleet Shares Slip Despite Record Q3 Revenue and Profit Gains

    PowerFleet, Inc. (NASDAQ:AIOT) posted stronger-than-expected third-quarter results on Monday, delivering record revenue and a sharp improvement in profitability, but its shares still fell more than 4% in premarket trading as investors digested updated guidance. The company reported third-quarter revenue of $113.5 million, beating analyst expectations of $111.78 million and rising 7% from $106.4 million a…

  • Sally Beauty Slides After Weak Q2 Outlook Overshadows Q1 Beat

    Sally Beauty Slides After Weak Q2 Outlook Overshadows Q1 Beat

    Sally Beauty Holdings, Inc. (NYSE:SBH) shares dropped more than 6% in premarket trading on Monday after the company posted better-than-expected first-quarter results but issued second-quarter guidance that fell short of market forecasts. The professional hair color retailer reported first-quarter adjusted earnings of $0.48 per share, ahead of analyst expectations of $0.46. Revenue totaled $943 million,…

  • Monday.com Slides as Revenue Outlook Disappoints Despite Q4 Beat

    Monday.com Slides as Revenue Outlook Disappoints Despite Q4 Beat

    Monday.com (NASDAQ:MNDY) shares sank more than 12% in premarket trading after the AI-powered work management platform issued fiscal 2026 revenue guidance that came in below market expectations, overshadowing a stronger-than-expected fourth quarter. For the fourth quarter, the company reported adjusted earnings of $1.04 per share, topping analyst forecasts of $0.92. Revenue rose 25% year over…

  • Micron Shares Slide After Report on Samsung’s Faster HBM4 Production Plans

    Micron Shares Slide After Report on Samsung’s Faster HBM4 Production Plans

    Micron Technology (NASDAQ:MU) shares fell about 3.2% on Monday after reports indicated that rival Samsung Electronics is set to begin mass production of next-generation high-bandwidth memory chips sooner than previously expected. According to South Korea’s Yonhap News Agency, Samsung plans to start large-scale production of HBM4 chips as early as this month. The components are…

  • Kyndryl Shares Sink After Q3 Miss and Weaker Full-Year Outlook

    Kyndryl Shares Sink After Q3 Miss and Weaker Full-Year Outlook

    Kyndryl Holdings (NYSE:KD) shares plunged more than 32% in premarket trading on Monday after the company reported third-quarter results that missed expectations and cut its revenue outlook for the full year. The IT infrastructure services provider posted adjusted earnings of $0.52 per share for the quarter ended December 31, 2025, well below the $0.67 analysts…

  • Inotiv Slides After Q1 Revenue Falls Short and Losses Deepen

    Inotiv Slides After Q1 Revenue Falls Short and Losses Deepen

    Inotiv, Inc. (NASDAQ:NOTV) shares fell about 3% in premarket trading on Monday after the company posted first-quarter fiscal 2026 results that missed expectations, with slower revenue growth and a wider loss. The contract research group reported first-quarter revenue of $120.9 million, a modest 0.8% increase from a year earlier but well below the analyst consensus…

  • Novo Nordisk Takes Legal Action Against Hims & Hers Over Compounded Semaglutide

    Novo Nordisk Takes Legal Action Against Hims & Hers Over Compounded Semaglutide

    Novo Nordisk (NYSE:NVO) has filed a patent infringement lawsuit against telehealth provider Hims & Hers (NYSE:HIMS) in the United States, targeting the company’s sale and promotion of compounded semaglutide products, according to a statement from the Danish drugmaker. Novo Nordisk alleges that Hims & Hers violated U.S. Patent 8,129,343 by marketing compounded versions of semaglutide…

  • Waters Slides After Q1 Outlook Falls Short Despite Solid Q4 Beat

    Waters Slides After Q1 Outlook Falls Short Despite Solid Q4 Beat

    Waters Corporation (NYSE:WAT) shares dropped more than 3% in premarket trading on Monday after the company issued first-quarter earnings guidance that missed market expectations, overshadowing better-than-expected fourth-quarter results. The analytical instruments group reported fourth-quarter adjusted earnings of $4.53 per share, narrowly topping analyst forecasts of $4.51. Revenue came in at $932 million, also slightly ahead…

  • Nexxen International Surges on Reported Takeover Interest

    Nexxen International Surges on Reported Takeover Interest

    Nexxen International (NASDAQ:NEXN) shares rallied about 18% in premarket trading on Monday following a report suggesting the advertising technology company has attracted acquisition interest. According to Sky News journalist Mark Kleinman, writing in a post on X, a potential buyer is considering an offer valuing Nexxen at no less than $10 per share. The prospect…